Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials

Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials

Abstract Tapinarof cream 1% (VTAMA®; Dermavant Sciences, Inc.) is a non-steroidal, topical, aryl hydrocarbon receptor agonist approved by the US Food and Drug Administration (FDA) to treat plaque psoriasis in adults and under investigation for the treatment of psoriasis in children down to 2 years o...

Full description

Saved in:
Bibliographic Details
Main Authors: Seemal R. Desai (Author), Linda Stein Gold (Author), Michael C. Cameron (Author), Alexandra Golant (Author), G. Michael Lewitt (Author), Matthew J. Bruno (Author), George Martin (Author), Philip M. Brown (Author), David S. Rubenstein (Author), Victoria Butners (Author), Anna M. Tallman (Author)
Format: Book
Published: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items